MIA FOCHT: Open Payments
NPI 1114773181 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $61 |
| Exact Sciences Corporation | 2 | $56 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Lilly USA, LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: The Cologuard Plus Collection Kit, Ozempic, BREZTRI, MOUNJARO, QULIPTA, VRAYLAR, AREXVY, OTEZLA.
Industry payments across DE — which companies pay providers there.
